Reply to A. Wang-Gillam et al

Affiliations

¹ Davendra P.S. Sohal, Cleveland Clinic, Cleveland, OH; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Daniel Laheru, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; and Alok A. Khorana, Cleveland Clinic, Cleveland, OH.

Comment

Davendra P S Sohal et al. J Clin Oncol. 2017.

. 2017 Feb 20;35(6):690-691.

doi: 10.1200/JCO.2016.70.7463. Epub 2016 Dec 5.

¹ Davendra P.S. Sohal, Cleveland Clinic, Cleveland, OH; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Daniel Laheru, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; and Alok A. Khorana, Cleveland Clinic, Cleveland, OH.

No abstract available

Comment on

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Sohal DP, Mangu PB, Khorana AA, Shah MA, Philip PA, O'Reilly EM, Uronis HE, Ramanathan RK, Crane CH, Engebretson A, Ruggiero JT, Copur MS, Lau M, Urba S, Laheru D. Sohal DP, et al. J Clin Oncol. 2016 Aug 10;34(23):2784-96. doi: 10.1200/JCO.2016.67.1412. Epub 2016 May 31. J Clin Oncol. 2016. PMID: 27247222 Free PMC article.
Nanoliposomal Irinotecan in the Clinical Practice Guideline for Metastatic Pancreatic Cancer: Applicability to Clinical Situations.
Wang-Gillam A, Von Hoff D, Siveke J, Hubner R, Belanger B, Pipas JM, Chen LT. Wang-Gillam A, et al. J Clin Oncol. 2017 Feb 20;35(6):689-690. doi: 10.1200/JCO.2016.70.1607. Epub 2016 Dec 5. J Clin Oncol. 2017. PMID: 27918719 No abstract available.